Donald Charles Brumley
About Donald Charles Brumley
Data last updated:
Donald Charles Brumley is a Director at Mycelium Sona Biotech Private Limited (since 2021). The company operates in Life Sciences. Mycelium Sona Biotech Private Limited reported revenue of ₹1.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mycelium Sona Biotech Private Limited U01409KA2021FTC143780 | Director | 13 Aug 2021 | 2021 | ₹1.75 Cr (FY 2025) | Active |
Board colleagues of Donald Charles Brumley
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muralidhar Padmanabha Rao | 03530287 | Mycelium Sona Biotech Private Limited | Director |
| Neville James Fielke | 09257130 | Mycelium Sona Biotech Private Limited | Director |
| Valliappa Chockalingam | 01753052 | Mycelium Sona Biotech Private Limited | Director |
| William Hush Allan Scott | 09257128 | Mycelium Sona Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Donald Charles Brumley
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Donald Charles Brumley
Donald Charles Brumley currently holds 1 directorship: Mycelium Sona Biotech Private Limited (Director, since 13 Aug 2021, revenue ₹1.75 Cr (FY 2025)).
Donald Charles Brumley was first appointed on 13 Aug 2021 as Director at Mycelium Sona Biotech Private Limited.
The current boards of Donald Charles Brumley's companies include Muralidhar Padmanabha Rao (Mycelium Sona Biotech Private Limited), Neville James Fielke (Mycelium Sona Biotech Private Limited), Valliappa Chockalingam (Mycelium Sona Biotech Private Limited), William Hush Allan Scott (Mycelium Sona Biotech Private Limited).